Skip to content

EGEIRO PHARMA

Open bankruptcy
Public limited companyfounded 2017Avenue Jean Mermoz 32, 6041 Charleroi, BelgiumKBO/BCE: BE 0684.906.013

A bankruptcy procedure is open for EGEIRO PHARMA according to publications in the Belgian Official Gazette; trustee: Pierre-Emmanuel Cornil.

Summary

The 2023 annual accounts show equity of €6.0m and a net result of -€1.6m.

EGEIRO PHARMAOpen bankruptcy

Are you a creditor?

Open bankruptcy Source: Belgian Official Gazette

The judgment is more than a year old: a claim can no longer be filed, not even late. The trustee knows whether anything will still be paid out.

The procedure

Court
Enterprise Court of Hainaut, Charleroi division
Declared bankrupt
17 March 2025
Supervising judge
Patrick Fautre
Official Gazette
21-03-2025 (pdf) ↗search the document for 2025/111887

Deadlines

Appeal or third-party opposition until
passed on 5 April 2025Fifteen days after the publication in the Official Gazette.art. XX.108, Code of Economic Law
File the claim in RegSol, the Belgian insolvency register, until
passed on 16 April 2025art. XX.104 and XX.155, Code of Economic Law
First verification report
passed on 14 May 2025Reclaim goods that are still yours, such as goods delivered under retention of title, before this day.art. XX.104 and XX.194, Code of Economic Law
Late claim until
passed on 17 March 2026A late claim shares only in what has not yet been paid out, and you bear its costs.art. XX.165, Code of Economic Law

Trustee

What to do now

  1. The deadlines to file your claim have passed, including for a late claim: that was possible until a year after the judgment.
  2. Ask the trustee whether anything will still be paid out and whether your claim was admitted.
  3. Follow the file in RegSol: the trustee's reports appear there.
  4. Ask your accountant about the VAT on the unpaid invoices: in a bankruptcy it can be recovered, subject to conditions.

The judgment is more than a year old: the deadline for a late claim (art. XX.165, Code of Economic Law) has passed too.

View the file in RegSol ↗ Follow Follow this bankruptcy: you are alerted when it is closed or reversed.

General information, not legal advice. If in doubt, the trustee, your lawyer or your accountant can help.Creditor guide for this company

Embed in an article

Writing about this bankruptcy? Embed the EGEIRO PHARMA company card in your article: name, enterprise number, its status in the KBO and the latest annual accounts, with a link to this dossier.

Preview
The preview appears here.
  • Stays current: the status follows the register, the figures are those of the latest filed accounts. No Checked score or verdict.
  • Light on your page: one small script and one data request, also answered from a cache; no cookies, no tracking.
  • Where scripts do not run (a newsletter, a feed reader) a plain link remains.

Overview

Activity
Manufacture of chemicals and chemical products
NACE 20130
2 sites
Size
€1.3moperating revenue 2023
Staff
7.5 FTE
Equity
€6.0m
Loss
-€1.6m
Financial health
Open bankruptcy: no score
Structure
Largest shareholder
LUXEMBOURG DEVELOPPEMENT EUROPE DEUX · 11.4%
Holdings
1
9 of 24 deeds read
Signalsraises riskOpen bankruptcyneutralFiled after the deadlineShow the evidence

Signals

Two signals.
raises riskneutral
raises risk · Open bankruptcy
Active bankruptcy procedure in the Belgian Official Gazette. Claims are handled by the appointed trustee. The KBO register also records: open bankruptcy.
Belgian Official Gazette
neutral · Filed after the deadline
The financial year that closed on 31-12-2023 was due by 31-07-2024 and was filed on 08-08-2024, 8 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 6 filings
Deviation from the deadline
2023
8 days late
2022
55 days early
2021
33 days early
2020
40 days early
2019
14 days early
2018
33 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 28 days before the deadline; the sector median (NACE 20) for financial year 2023 is 16 days before the deadline, and 28% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. OpeningEnterprise Court of Hainaut, Charleroi…
  2. Amendment of the articlesCorrection · Capital
  3. Capital & sharesFinancial instrument · Capital increase…

Key points

  • Risk: Declared bankrupttrustee: Pierre-Emmanuel Cornil 17-03-2025 View
  • Caution: Staff fell in 2023from 11.9 FTE to 7.5 FTE ▼ 37.0% View
  • Board2 directors in office 2 View

By topic

Financials

Financial year
2023
Turnover
€117,839
Loss
-€1.6m
Solvency
80.3%
Turnover▲ 25.3%
Net result
20212023
Go to Financials

Board & ownership

Board
2 members
Largest shareholder
LUXEMBOURG DEVELOPPEMENT EUROPE DEUX · 11.4%
  • HYUNH-KIM-BANG Emmanuel GilbertDirector
  • TERRASSE GaëtanDaily manager
Go to Board & ownership

Timeline

Events
20
Since
2019
  1. 13-12-2024Resignations: ENRICO BASTIANELLI SRL (director) and Catherine…
  2. 22-11-2024Resignation: ENRICO BASTIANELLI SRL (daily management delegate)
  3. 12-11-2024Resignations: Simon Wheeler, Nesya Goris LifeSciences Consulting…
Go to Timeline

Company details

Sites
2
Legal form
Public limited company
Activity
Manufacture of chemicals and chemical productsNACE 20130
Founded
22-11-2017
Year ends
31-12
Peppol
Not found in the Peppol directory
Go to Company details

Go further with this company

Investigating this company? Keep it with today's facts in a case file.